Clinical application of autologous three-cellular cultured skin substitutes based on esterified hyaluronic acid scaffold: Our experience

In Vivo

Volumn 23, Issue 6, 2009, Pages 991-1003

  Scuderi, Nicolò ^a   Anniboletti, Tommaso ^a   Carlesimo, Bruno ^a   Onesti, Maria Giuseppina ^a  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

Author keywords

Autologous; Bioengineered; CSS; Culture; Fibroblasts; HYAFF 11; Keratinocytes; Skin

Indexed keywords

HYALURONIC ACID; TISSUE SCAFFOLD;

ADOLESCENT; ADULT; ARTICLE; BASEMENT MEMBRANE; CELL CULTURE; CHILD; CLINICAL ARTICLE; CLINICAL EVALUATION; CLINICAL TRIAL; DERMIS; EPITHELIUM; EPITHELIUM CELL; ESTHETICS; FEMALE; FIBROBLAST; FOLLOW UP; GRAFT SURVIVAL; HUMAN; HUMAN TISSUE; KERATINOCYTE; MALE; MELANOCYTE; PRESCHOOL CHILD; SCHOOL CHILD; SKIN AUTOGRAFT; SKIN BIOPSY; SKIN DISEASE; STROMA; SUBCUTANEOUS TISSUE; TISSUE ENGINEERING; TREATMENT OUTCOME;

EID: 75149132070     PISSN: 0258851X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (36)

1. O'Connor NE, Mulliken JB, Banks-Schlegel S, Kehinde O and Green H: Grafting of burns with cultured epithelium prepared from autologous epidermal cells. Lancet 1(8211): 75-78, 1981.
2. Boyce ST, Kagan RJ, Greenhalgh DG, Warner P, Yakuboff KP, Palmieri T and Warden GD: Cultured skin substitutes reduce requirements for harvesting of skin autograft for closure of excised, full-thickness burns. J Trauma 60(4): 821-829, 2006.
3. Nie X, Zhang JY, Cai KJ, Yang MH, Xiao AH, Da Hu H, Liu LY, Wang HJ, Wen N and Jin Y: Cosmetic improvement in various acute skin defects treated with tissue-engineered skin. Artif Organs 31(9): 703-710, 2007.
4. Supp DM, Karpinski AC and Boyce ST: Expression of human beta defensins HBD-1, HBD-2, and HBD-3 in cultured keratinocytes and skin substitutes. Burns 30(7): 643-648, 2004.
5. Boyce ST and Warden GD: Principles and practices for treatment of cutaneous wounds with cultured skin substitutes. Am J Surg 183(4): 445-456, 2002.
6. Boyce ST, Supp AP, Harriger MD, Pickens WL, Wickert RR and Hoath SB: Surface electrical capacitance as a noninvasive index of epidermal barrier in cultured skin substitutes in athymic mice. J Invest Dermatol 107(1): 82-87, 1996.
7. Boyce ST, Supp AP, Swope VB, Warden GD:Vitamin C regulates keratinocyte viability, epidermal barrier, and basement membrane formation in vitro, and reduces wound contraction after grafting of cultured skin substitutes. J Invest Dermatol 118(4): 565-572, 2002.
8. Boyce ST, Kagan RJ, Meyer NA, Yakuboff KP and Warden GD: Cultured skin substitutes combined with Integra to replace native skin autograft and allograft for closure of full-thickness burns. J Burn Care Rehabil 20(6): 453-461, 1999.
9. Comment in: J Burn Care Rehabil 22(2): 197-198, 2001,
10. J Burn Care Rehabil 22(2): 198-199,2001.
11. Boyce ST, Kagan RJ, Yakuboff KP, Meyer NA, Rieman MT, Greenhalgh DG and Warden GD: Cultured skin substitutes reduce donor skin harvesting for closure of excised, full-thickness burns. Ann Surg 235(2): 269-279, 2002.
12. Hansbrough JF, Boyce ST, Cooper ML and Foreman TJ: Burn wound closure with cultured autologous keratinocytes and fibroblasts attached to a collagen-glycosaminoglycan substrate. JAMA 262(15): 2125-2130, 1989.
13. Passaretti D, Billmire D, Kagan R, Corcoran J and Boyce S: Autologous cultured skin substitutes conserve donor autograft in elective treatment of congenital giant melanocytic nevus. Plast Reconstr Surg 114(6): 1523-1528, 2004.
14. Boyce ST, Glatter R and Kitzmiller WJ: Treatment of chronic wounds with cultured skin substitutes: a pilot study. Wounds 7: 24-29, 1995.
15. Supp DM, Supp AP, Bell S and Boyce ST: Enhanced vascularization of cultured skin substitutes genetically modified to overexpress vascular endothelial growth factor. J Invest Dermatol 114(1): 5-13, 2000.
16. Supp DM, Bell SM, Morgan JR and Boyce ST: Genetic modification of cultured skin substitutes by transduction of human keratinocytes and fibroblasts with platelet-derived growth factor-A. Wound Repair Regen 8(1): 26-35, 2000.
17. Liu Y, Suwa F, Wang X, Takemura A, Fang YR, Li Y, Zhao Y and Jin Y: Reconstruction of a tissue engineered skin containing melanocytes. Cell Biol Int 31(9): 985-990, 2007.
18. Scuderi N, Onesti MG, Bistoni G, Ceccarelli S, Rotolo S, Angeloni A and Marchese C: The clinical application of autologous bioengineered skin based on a hyaluronic acid scaffold. Biomaterials 29(11): 1620-1629, 2008.
19. Stark HJ, Willhauck MJ, Mirancea N, Boehnke K, Nord I, Breitkreutz D, Pavesio A, Boukamp P and Fusenig NE: Authentic fibroblast matrix in dermal equivalents normalises epidermal histogenesis and dermoepidermal junction in organotypic co-culture. Eur J Cell Biol 83(11-12): 631-645, 2004.
20. Stark HJ, Szabowski A, Fusenig NE and Maas-Szabowski N: Organotypic cocultures as skin equivalents: a complex and sophisticated in vitro system. Biol Proced Online 6: 55-60,2004.
21. Zacchi V, Soranzo C, Cortivo R, Radice M, Brun P and Abatangelo G: In vitro engineering of human skin-like tissue. J Biomed Mater Res 40(2): 187-194, 1998.
22. Campoccia D, Doherty P, Radice M, Brun P, Abatangelo G and Williams DF: Semisynthetic resorbable materials from hyaluronan esterification. Biomaterials 19(23): 2101-2127,1998.
23. Galassi G, Brun P, Radice M, Cortivo R, Zanon GF, Genovese P and Abatangelo G: In vitro reconstructed dermis implanted in human wounds: degradation studies of the HA-based supporting scaffold. Biomaterials 21(21): 2183-2191, 2000.
24. Aigner J, Tegeler J, Hutzler P, Campoccia D, Pavesio A, Hammer C, Kastenbauer E and Naumann A: Cartilage tissue engineering with novel nonwoven structured biomaterial based on hyaluronic acid benzyl ester. J Biomed Mater Res 42(2): 172-181,1998.
25. Brun P, Abatangelo G, Radice M, Zacchi V, Guidolin D, Daga Gordini D and Cortivo R: Chondrocyte aggregation and reorganization into three-dimensional scaffolds. J Biomed Mater Res 46(3): 337-346, 1999.
26. Benedetti L, Cortivo R, Berti T, Berti A, Pea F, Mazzo M, Moras M and Abatangelo G: Biocompatibility and biodegradation of different hyaluronan derivatives (HYAFF) implanted in rats. Biomaterials 14(15): 1154-1160, 1993.
27. Cortivo R, Brun P, Rastrelli A and Abatangelo G: In vitro studies on biocompatibility of hyaluronic acid esters. Biomaterials 12(8): 727-730, 1991.
28. Rhodes AR, Wood WC, Sober AJ and Mihm MC Jr: Nonepidermal origin of malignant melanoma associated with a giant congenital nevocellular nevus. Plast Reconstr Surg 67(6): 782-790,1981.
29. Avitabile T, Marano, Castiglione F, Bucolo C, Cro M, Ambrosio L, Ferrauto C and Reibaldi A: Biocompatibility and biodégradation of intravitreal hyaluronan implants in rabbits. Biomaterials 22(3): 195-200,2001.
30. Price RD, Das-Gupta V, Leigh IM and Navsaria HA: A comparison of tissue-engineered hyaluronic acid dermal matrices in a human wound model. Tissue Eng 12(10): 2985-2995,2006.
31. Rosdy M and Clauss LC: Terminal epidermal differentiation of human keratinocytes grown in chemically defined medium on inert filter substrates at the air-liquid interface. J Invest Dermatol 95(4): 409-414, 1990.
32. Fartasch M and Ponec M: Improved barrier structure formation in air-exposed human keratinocyte culture systems. J Invest Dermatol 102(3): 366-374, 1994.
33. Bernstam LI, Vaughan FL and Bernstein IA: Stratified cornified primary cultures of human keratinocytes grown on microporous membranes at the air-liquid interface. J Dermatol Sci 1(3): 173-181, 1990.
34. Supp DM, Wilson-Landy K and Boyce ST: Human dermal microvascular endothelial cells form vascular analogs in cultured skin substitutes after grafting to athymic mice. FASEB J 16(8): 797-804, 2002.
35. Tonello C, Vindigni V, Zavan B, Abatangelo S, Abatangelo G, Brun P and Cortivo R: In vitro reconstruction of an endothelialized skin substitute provided with a microcapillary network using biopolymer scaffolds. FASEB J 19(11): 1546-1548,2005.
36. Rudolph R: The effect of skin graft preparation on wound contraction. Surg Gynecol Obstet 142: 49-56,1976.